Projects per year
Projects
- 5 Active
Search results
-
Active
PRiZM+: A phase II Platform study for Relapsed and Refractory prImary CNS lymphoma with Zanubrutinib
Boucher, B., Jackson, A., Fox, S. & Craddock, C.
1/04/22 → 30/06/26
Project: Research
-
A randomised phase 2 study of ASTX727 versus best supportive care in MDS/MPN Overlap Syndromes
Fox, S., Boucher, B., Craddock, C. & Jackson, A.
1/03/21 → 31/08/25
Project: Research
-
PACE: The impact of COVID-19 on patients with AML undergoing chemotherapy: an epidemiological study
Jackson, A., Craddock, C., Loke, J., Boucher, B. & Fox, S.
CELGENE INTERNATIONAL II SARL, BLOODWISE
1/04/20 → 30/06/25
Project: Research
-
PROMise: Investigation into the combination of a Plexxikon BETi with ruxolitinib in patients with high or intermediate-2 risk myelofibrosis not recieving an adequate respnse with ruxolitinib alone (Adam Mead)
Craddock, C., Fox, S. & Boucher, B.
Cancer Research Uk, PLEXXIKON INC, Opna-IO LLC
1/05/19 → 31/12/26
Project: Research
-
STELLAR: A Phase 2, Randomised Study of CHOP-R in Combination with acalabrutinib followed by acalabrutinib maintenance compared to CHOP-R followed by acalabrutinib at disease progression for patients...
Craddock, C., Jackson, A., Boucher, B., Siddique, S. & Wheatley, K.
7/12/18 → 6/06/26
Project: Research